Effects of Moderate Physical Activity on Glycemic Control in Type 2 Diabetes Mellitus
Primary Purpose
Type 2 Diabetes Mellitus
Status
Completed
Phase
Not Applicable
Locations
Pakistan
Study Type
Interventional
Intervention
Brisk Walk
Strength training
Aerobic Exercises
Sponsored by

About this trial
This is an interventional other trial for Type 2 Diabetes Mellitus
Eligibility Criteria
Inclusion Criteria:
- Participants falling in this category would be recruited into the study.
- Male/female
- Diabetic type 2 patients
- Age: 30-70 years
- BMI >25
- Overweight
- Fat % in male> 25
- Fat % in female >35
- HbA1c level more than 48mmol/mol or >6.5%
- Fasting Plasma Glucose level >126 mg/dl (7.0 mmol/l)
- Random Plasma glucose level >200 mg/dl (11.1 mmol/l)
- Physically active ( have no mobility problems)
Exclusion Criteria:
- Participant failing to fall in this category would be excluded of the study.
- Type 1 diabetes
- Insulin dependant type 2 diabetes
- Gestational Diabetes
- Hypertension
- Cigarette smoking
- Cardiovascular Disease
- Cerebrovascular disease
- Cardiopulmonary Disorders
- Cognition Problems
- Peripheral Artery Disease
- Dyslipidemia
- Proliferative or preproliferative retinopathy
- Nephropathy
- Neuropathy
Sites / Locations
- Riphah Rehabilitation Center
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm Type
Experimental
Experimental
Experimental
Arm Label
Brisk walk
Aerobic Training
Strength Training
Arm Description
Outcomes
Primary Outcome Measures
HbA1c Levels
Reduction in HbA1c levels
Secondary Outcome Measures
Full Information
NCT ID
NCT04924777
First Posted
June 11, 2021
Last Updated
November 24, 2021
Sponsor
Riphah International University
1. Study Identification
Unique Protocol Identification Number
NCT04924777
Brief Title
Effects of Moderate Physical Activity on Glycemic Control in Type 2 Diabetes Mellitus
Official Title
Effects of Moderate Physical Activity on Glycemic Control in Type 2 Diabetes Mellitus
Study Type
Interventional
2. Study Status
Record Verification Date
November 2021
Overall Recruitment Status
Completed
Study Start Date
April 1, 2021 (Actual)
Primary Completion Date
July 31, 2021 (Actual)
Study Completion Date
July 31, 2021 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Riphah International University
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
The study design is to determine the effectiveness of moderate physical activity on g;lycemic control in type 2 diabetes mellitus.
Detailed Description
To the best of authors knowledge so far the studies have been conducted on different modes of moderate physical activity on glycemic control in type 2 diabetes, current study goal is to evaluate which mode of moderate physical activity has more significant result on glycemic control in type 2 diabetes and is sustainable in Pakistani society according to the socioeconomic status and cost effectiveness of the modes of moderate physical activity.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Type 2 Diabetes Mellitus
7. Study Design
Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
48 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Brisk walk
Arm Type
Experimental
Arm Title
Aerobic Training
Arm Type
Experimental
Arm Title
Strength Training
Arm Type
Experimental
Intervention Type
Other
Intervention Name(s)
Brisk Walk
Intervention Description
1-Brisk walk for 30 minutes 2-5 days a week 3-3months
Intervention Type
Other
Intervention Name(s)
Strength training
Intervention Description
1-Strength Training Exercises for 30 minutes. 2-5 days a week 3-3 months
Intervention Type
Other
Intervention Name(s)
Aerobic Exercises
Intervention Description
1-Aerobic exercises for 30 minutes 2-5 Days a week 3-3months
Primary Outcome Measure Information:
Title
HbA1c Levels
Description
Reduction in HbA1c levels
Time Frame
3 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
30 Years
Maximum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Participants falling in this category would be recruited into the study.
Male/female
Diabetic type 2 patients
Age: 30-70 years
BMI >25
Overweight
Fat % in male> 25
Fat % in female >35
HbA1c level more than 48mmol/mol or >6.5%
Fasting Plasma Glucose level >126 mg/dl (7.0 mmol/l)
Random Plasma glucose level >200 mg/dl (11.1 mmol/l)
Physically active ( have no mobility problems)
Exclusion Criteria:
Participant failing to fall in this category would be excluded of the study.
Type 1 diabetes
Insulin dependant type 2 diabetes
Gestational Diabetes
Hypertension
Cigarette smoking
Cardiovascular Disease
Cerebrovascular disease
Cardiopulmonary Disorders
Cognition Problems
Peripheral Artery Disease
Dyslipidemia
Proliferative or preproliferative retinopathy
Nephropathy
Neuropathy
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Waqar Ahmad Awan
Organizational Affiliation
Riphah International University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Riphah Rehabilitation Center
City
Islamabad
ZIP/Postal Code
44000
Country
Pakistan
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Effects of Moderate Physical Activity on Glycemic Control in Type 2 Diabetes Mellitus
We'll reach out to this number within 24 hrs